Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Vanderbilt University |
---|---|
Information provided by: | Vanderbilt University |
ClinicalTrials.gov Identifier: | NCT00179049 |
The investigators' hypothesis is that the graft-versus-tumor effect can be enhanced while minimizing the complications of graft-versus-host disease.
Condition |
---|
Hematopoietic Stem Cell Transplantation Graft vs Host Disease |
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Official Title: | Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant (HSCT) |
Estimated Enrollment: | 100 |
Study Start Date: | April 2003 |
Study Completion Date: | April 2008 |
The investigators' hypothesis is that the graft-versus-tumor effect can be enhanced while minimizing the complications of graft-versus-host disease (GVHD) by determining the qualitative and quantitative changes in T regulatory cells throughout the transplant process. Their understanding of this can lead to new treatment strategies and improved clinical therapeutic implications.
Ages Eligible for Study: | 18 Years to 70 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Patients 18-70 years old undergoing either autologous transplant or allogeneic transplant for various hematologic conditions
Inclusion Criteria:
Exclusion Criteria:
United States, Tennessee | |
Vanderbilt University Medical Center | |
Nashville, Tennessee, United States, 37232-5505 |
Principal Investigator: | Adetola A Kassim, M.D. | Vanderbilt University |
Responsible Party: | Vanderbilt University ( Adetola A. Kassim, MD ) |
Study ID Numbers: | BMT 030261 |
Study First Received: | September 13, 2005 |
Last Updated: | December 12, 2008 |
ClinicalTrials.gov Identifier: | NCT00179049 |
Health Authority: | United States: Institutional Review Board |
T-Lymphocyte Subsets |
Graft versus host disease Graft vs Host Disease Homologous wasting disease |
Immune System Diseases |